|
US4411890A
(en)
|
1981-04-14 |
1983-10-25 |
Beckman Instruments, Inc. |
Synthetic peptides having pituitary growth hormone releasing activity
|
|
SE376722B
(hu)
|
1971-03-30 |
1975-06-09 |
S E Friberg |
|
|
BE795516A
(fr)
|
1972-02-17 |
1973-08-16 |
Ciba Geigy |
Preparations de peptides huileuses et injectables et procede pour leur preparation
|
|
US4489097A
(en)
|
1976-07-28 |
1984-12-18 |
The Procter & Gamble Company |
Intravenous solutions with antimicrobial agent
|
|
JPS53107408A
(en)
|
1977-02-28 |
1978-09-19 |
Yamanouchi Pharmaceut Co Ltd |
Micellar preparation for rectal infusion
|
|
GB2051574B
(en)
|
1979-05-10 |
1984-01-18 |
Kyoto Pharma Ind |
Adjuvant for promoting absorption of pharmacologically active substances through the rectum
|
|
US4544500A
(en)
|
1982-04-14 |
1985-10-01 |
Scripps Clinic And Research Foundation |
Synthetic foot and mouth disease antigen
|
|
US4589881A
(en)
|
1982-08-04 |
1986-05-20 |
La Jolla Cancer Research Foundation |
Polypeptide
|
|
US4508828A
(en)
|
1983-03-21 |
1985-04-02 |
Immuno Nuclear Corporation |
Bioassay of parathyroid hormone
|
|
US4572915A
(en)
|
1984-05-01 |
1986-02-25 |
Bioglan Laboratories |
Clear micellized solutions of fat soluble essential nutrients
|
|
US4985404A
(en)
|
1984-10-04 |
1991-01-15 |
Monsanto Company |
Prolonged release of biologically active polypeptides
|
|
US4650665A
(en)
|
1985-02-08 |
1987-03-17 |
Ethicon, Inc. |
Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
|
|
US4650787A
(en)
*
|
1985-04-25 |
1987-03-17 |
Schally Andrew Victor |
Biologically active octapeptides
|
|
US4732971A
(en)
|
1985-06-03 |
1988-03-22 |
Eli Lilly And Company |
Synthetic vaccines for foot and mouth disease
|
|
HU198626B
(en)
|
1986-05-27 |
1989-11-28 |
Sandoz Ag |
Process for producing pharmaceutical compositions comprising somatostatin analogues as active ingredient
|
|
DE3709861A1
(de)
|
1987-03-25 |
1988-10-06 |
Henkel Kgaa |
Emulgierende suppositoriengrundmassen und daraus hergestellte zaepfchen
|
|
US4839344A
(en)
|
1987-06-12 |
1989-06-13 |
Eastman Kodak Company |
Polypeptide compounds having growth hormone releasing activity
|
|
DE3738236A1
(de)
|
1987-11-11 |
1989-05-24 |
Euro Celtique Sa |
Beisskapsel
|
|
FR2627696B1
(fr)
|
1988-02-26 |
1991-09-13 |
Fournier Innovation Synergie |
Nouvelle forme galenique du fenofibrate
|
|
NO179479C
(no)
|
1988-03-11 |
1996-10-16 |
Teikoku Seiyaku Kk |
Fremgangsmåte for fremstilling av et intravaginalt farmasöytisk preparat
|
|
GB8822857D0
(en)
|
1988-09-29 |
1988-11-02 |
Patralan Ltd |
Pharmaceutical formulations
|
|
ZA898331B
(en)
|
1988-11-22 |
1990-07-25 |
Hoffmann La Roche |
Pharmaceutical compositions
|
|
NZ233403A
(en)
|
1989-04-28 |
1992-09-25 |
Mcneil Ppc Inc |
Simulated capsule-like medicament
|
|
ATE113471T1
(de)
|
1989-08-17 |
1994-11-15 |
Cortecs Ltd |
Arzneiformulierungen.
|
|
US5665384A
(en)
|
1990-04-06 |
1997-09-09 |
Rhone-Poulenc Rorer S.A. |
Oily capsules of ketoprofen
|
|
GB9013448D0
(en)
|
1990-06-15 |
1990-08-08 |
Sandoz Ltd |
Pharmaceutical resorption-improved somatostatin compositions,their preparation and use
|
|
SE9003100D0
(sv)
|
1990-09-28 |
1990-09-28 |
Kabivitrum Ab |
Lipid formulation system
|
|
IT1243435B
(it)
|
1990-10-05 |
1994-06-10 |
Altergon Sa |
Composizioni farmaceutiche per uso topico comprendenti acido ialuronico sale sodico e sostanze disinfettanti
|
|
US5254331A
(en)
|
1991-09-12 |
1993-10-19 |
Chanel, Inc. |
Skin cream composition
|
|
EP0661052A1
(en)
|
1991-11-08 |
1995-07-05 |
Kyoto Pharmaceutical Industries, Ltd. |
Pharmaceutical preparation containing prostaglandin compound for rectal or vaginal administration
|
|
US5206219A
(en)
|
1991-11-25 |
1993-04-27 |
Applied Analytical Industries, Inc. |
Oral compositions of proteinaceous medicaments
|
|
US5478577A
(en)
|
1993-11-23 |
1995-12-26 |
Euroceltique, S.A. |
Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
|
|
US5246716A
(en)
|
1992-01-10 |
1993-09-21 |
W. Neudorff Gmbh Kg |
Fatty acid-based antifungal composition having residual activity
|
|
DE4203170A1
(de)
|
1992-02-05 |
1993-08-12 |
Basf Ag |
Verfahren zur herstellung von e-oximethern von phenylglyoxylsaeureestern
|
|
GB9203769D0
(en)
|
1992-02-21 |
1992-04-08 |
Sandoz Ltd |
Improvements in or relating to organic compounds
|
|
IL103224A
(en)
|
1992-09-18 |
1998-08-16 |
Teva Pharma |
Stabilized pharmaceutical compositions containing derivatives of vitamins d2 and d3
|
|
US5288492A
(en)
|
1992-11-13 |
1994-02-22 |
Morris Michael A |
Decongestant composition containing aloe vera
|
|
DK17093D0
(da)
|
1993-02-15 |
1993-02-15 |
Lyfjathroun H F |
Farmaceutisk praeparat til topisk administrering af antigener og/eller vacciner til pattedyr via slimhinder
|
|
IT1263840B
(it)
|
1993-03-30 |
1996-09-04 |
Giuseppe Furiosi |
Formulazioni orali di ubidecarenone in forma di capsule
|
|
US5318781A
(en)
|
1993-04-06 |
1994-06-07 |
Hoffmann-La Roche Inc. |
Absorption enhancement of antibiotics
|
|
SE9302135D0
(sv)
|
1993-06-18 |
1993-06-18 |
Kabi Pharmacia Ab |
New pharmaceutical composition
|
|
US5506203C1
(en)
|
1993-06-24 |
2001-02-06 |
Astra Ab |
Systemic administration of a therapeutic preparation
|
|
TW402506B
(en)
|
1993-06-24 |
2000-08-21 |
Astra Ab |
Therapeutic preparation for inhalation
|
|
US5462726A
(en)
|
1993-12-17 |
1995-10-31 |
Bristol-Myers Squibb Company |
Method of inhibiting side effects of solvents containing ricinoleic acid or castor oil or derivatives thereof employing a thromboxane A2 receptor antagonist and pharmaceutical compositions containing such solvents
|
|
GB9405304D0
(en)
|
1994-03-16 |
1994-04-27 |
Scherer Ltd R P |
Delivery systems for hydrophobic drugs
|
|
US5561115A
(en)
|
1994-08-10 |
1996-10-01 |
Bayer Corporation |
Low temperature albumin fractionation using sodium caprylate as a partitioning agent
|
|
GB9417524D0
(en)
|
1994-08-31 |
1994-10-19 |
Cortecs Ltd |
Pharmaceutical compositions
|
|
EP0800828A4
(en)
|
1994-12-28 |
1999-03-31 |
Teikoku Hormone Mfg Co Ltd |
TRANSMUCOSAL PREPARATION
|
|
US5708017A
(en)
|
1995-04-04 |
1998-01-13 |
Merck & Co., Inc. |
Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors
|
|
US5827534A
(en)
|
1995-05-24 |
1998-10-27 |
University Of Maryland At Baltimore |
Oral dosage composition comprising zonnula occludens toxin and a therapeutic agent for intestinal delivery
|
|
US6696413B2
(en)
|
1995-06-16 |
2004-02-24 |
Hexal Ag |
Pharmaceutical preparation with cyclosporin A
|
|
GB9516268D0
(en)
|
1995-08-08 |
1995-10-11 |
Danbiosyst Uk |
Compositiion for enhanced uptake of polar drugs from the colon
|
|
US5686488A
(en)
|
1995-08-25 |
1997-11-11 |
Alcon Laboratories, Inc. |
Polyethoxylated castor oil products as anti-inflammatory agents
|
|
EP0760237A1
(en)
|
1995-08-30 |
1997-03-05 |
Cipla Limited |
Oil-in-water microemulsions
|
|
US5665711A
(en)
|
1995-12-12 |
1997-09-09 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Antitumor composition for oral administration
|
|
US5858401A
(en)
|
1996-01-22 |
1999-01-12 |
Sidmak Laboratories, Inc. |
Pharmaceutical composition for cyclosporines
|
|
US6280745B1
(en)
|
1997-12-23 |
2001-08-28 |
Alliance Pharmaceutical Corp. |
Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions
|
|
DK0889722T3
(da)
|
1996-03-28 |
2003-02-10 |
Takeda Chemical Industries Ltd |
Præparat med forsinket frigivelse og fremstilling deraf
|
|
US6214792B1
(en)
|
1996-04-12 |
2001-04-10 |
David Lew Simon |
Method for treating acute and severe diarrhea
|
|
US5726154A
(en)
|
1996-06-28 |
1998-03-10 |
University Of Utah Research Foundation |
Stabilization and oral delivery of calcitonin
|
|
EP1024833A1
(en)
|
1996-07-11 |
2000-08-09 |
Farmarc Nederland B.V. |
Pharmaceutical composition containing acid addition salt of basic drug
|
|
US6512010B1
(en)
|
1996-07-15 |
2003-01-28 |
Alza Corporation |
Formulations for the administration of fluoxetine
|
|
US5760096A
(en)
|
1996-10-18 |
1998-06-02 |
Thornfeldt; Carl R. |
Potent penetration enhancers
|
|
US7091183B1
(en)
|
1996-12-03 |
2006-08-15 |
Boston Medical Center Corporation |
Specific antagonists for glucose-dependent insulinotropic polypeptide (GIP)
|
|
US6193986B1
(en)
|
1997-02-25 |
2001-02-27 |
The Nisshin Oil Mills, Ltd. |
Oily composition with increased stability and process for producing the same
|
|
JPH10265380A
(ja)
|
1997-03-17 |
1998-10-06 |
Bristol Myers Squibb Co |
抗ガン剤
|
|
EP0973498B1
(en)
|
1997-03-25 |
2005-01-12 |
Takeda Chemical Industries, Ltd. |
Gastrointestinal mucosa-adherent pharmaceutical composition
|
|
DE69807281T2
(de)
|
1997-05-14 |
2003-04-17 |
Mitsubishi Chemical Corp., Tokio/Tokyo |
Difluprednat enthaltende Zusammensetzungen
|
|
IT1296914B1
(it)
|
1997-12-01 |
1999-08-03 |
Maria Rosa Gasco |
Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera
|
|
IL123143A
(en)
|
1998-02-02 |
2001-08-26 |
Agis Ind 1983 Ltd |
Pharmaceutical compositions containing mupirocin
|
|
JPH11246439A
(ja)
|
1998-03-02 |
1999-09-14 |
Hisamitsu Pharmaceut Co Inc |
経粘膜用吸収促進剤
|
|
US6326360B1
(en)
|
1998-03-11 |
2001-12-04 |
Grelan Pharmaceuticals Co., Ltd. |
Bubbling enteric coated preparations
|
|
CA2269050A1
(en)
|
1998-04-14 |
1999-10-14 |
Shigeo Yanai |
Method for transdermal administration of gp iib/iiia antagonist
|
|
BR9912203A
(pt)
|
1998-06-26 |
2001-04-10 |
Pfizer Productis Inc |
Processo melhorado para a preparação de aductos de base de schiff de aminas com o-hidroxialdeìdos e composições de matéria com base neles
|
|
US6150333A
(en)
|
1998-07-30 |
2000-11-21 |
Biomeasure, Inc. |
Methods of using a somatostatin analogue
|
|
US6284223B1
(en)
|
1998-10-15 |
2001-09-04 |
Fluoroprobe, Inc. |
Method for viewing tumor tissue located within a body cavity
|
|
IT1302682B1
(it)
|
1998-10-16 |
2000-09-29 |
Formenti Farmaceutici Spa |
Composizioni farmaceutiche orali contenenti buprenorfina
|
|
GB9823246D0
(en)
|
1998-10-24 |
1998-12-16 |
Danbiosyst Uk |
A nasal drug delivery composition
|
|
US6838091B2
(en)
|
1998-12-18 |
2005-01-04 |
Abbott Laboratories |
Formulations comprising lipid-regulating agents
|
|
US6368622B2
(en)
|
1999-01-29 |
2002-04-09 |
Abbott Laboratories |
Process for preparing solid formulations of lipid regulating agents with enhanced dissolution and absorption
|
|
WO2000047203A1
(en)
|
1999-02-12 |
2000-08-17 |
Mqs, Inc. |
Formulation and system for intra-oral delivery of pharmaceutical agents
|
|
EP1154761B1
(en)
|
1999-02-22 |
2008-02-20 |
Merrion Research I Limited |
Solid oral dosage form containing an enhancer
|
|
US8119159B2
(en)
|
1999-02-22 |
2012-02-21 |
Merrion Research Iii Limited |
Solid oral dosage form containing an enhancer
|
|
US20070148228A1
(en)
|
1999-02-22 |
2007-06-28 |
Merrion Research I Limited |
Solid oral dosage form containing an enhancer
|
|
US7658938B2
(en)
|
1999-02-22 |
2010-02-09 |
Merrion Reasearch III Limited |
Solid oral dosage form containing an enhancer
|
|
US6267985B1
(en)
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
|
US6383527B1
(en)
|
1999-03-04 |
2002-05-07 |
Nps Pharmaceuticals, Inc. |
Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a NSAID
|
|
US6632443B2
(en)
|
2000-02-23 |
2003-10-14 |
National Research Council Of Canada |
Water-soluble compositions of bioactive lipophilic compounds
|
|
JP2003501404A
(ja)
|
1999-06-04 |
2003-01-14 |
デルルックス ファーマシューティカル コーポレイション |
薬剤の脱水粒子からなる製剤およびこれの調製方法
|
|
US20030235595A1
(en)
|
1999-06-30 |
2003-12-25 |
Feng-Jing Chen |
Oil-containing, orally administrable pharmaceutical composition for improved delivery of a therapeutic agent
|
|
US6159935A
(en)
|
1999-11-29 |
2000-12-12 |
Pharmacia & Upjohn Co. |
Method for preventing diarrhea
|
|
FR2803202B1
(fr)
|
2000-01-03 |
2004-04-16 |
Capsulis |
Compositions pharmaceutiques destinees a une adminstration par voie orale
|
|
GB0018891D0
(en)
|
2000-08-01 |
2000-09-20 |
Novartis Ag |
Organic compounds
|
|
CN1141974C
(zh)
|
2000-06-07 |
2004-03-17 |
张昊 |
结肠定位释放的口服生物制剂
|
|
US6664234B1
(en)
|
2000-06-30 |
2003-12-16 |
Monsanto Technology Llc |
Non-aqueous injectable formulation preparation with pH adjusted for extended release of somatotropin
|
|
FR2811571B1
(fr)
|
2000-07-11 |
2002-10-11 |
Flamel Tech Sa |
Composition pharmaceutique orale, permettant la liberation controlee et l'absorption prolongee d'un principe actif
|
|
US20020091623A1
(en)
|
2000-12-04 |
2002-07-11 |
Daniels Alan F. |
System and methods for an electronic real estate trading environment
|
|
NZ541140A
(en)
|
2001-04-18 |
2006-11-30 |
Prometic Biosciences Inc |
Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
|
|
EP1392272B1
(en)
|
2001-05-11 |
2014-08-06 |
Merrion Research III Limited |
Permeation enhancers
|
|
US6528667B2
(en)
|
2001-05-14 |
2003-03-04 |
Phoenix Research Corporation |
Phosphated castor oil and derivatives
|
|
US20030070584A1
(en)
|
2001-05-15 |
2003-04-17 |
Cynthia Gulian |
Dip coating compositions containing cellulose ethers
|
|
JP4570357B2
(ja)
|
2001-07-06 |
2010-10-27 |
ライフサイクル ファーマ エー／エス |
制御された凝集
|
|
US6720002B2
(en)
|
2001-07-20 |
2004-04-13 |
R.P. Scherer Technologies, Inc. |
Antihistamine formulations for soft capsule dosage forms
|
|
CN1335182A
(zh)
|
2001-08-08 |
2002-02-13 |
华中科技大学 |
胰岛素口腔喷剂及其制备工艺
|
|
KR100425755B1
(ko)
|
2001-08-27 |
2004-04-03 |
주식회사 원진신약 |
이트라코나졸을 함유하는 조성물 및 그 제조방법
|
|
CA2460867C
(en)
|
2001-09-19 |
2011-04-12 |
Elan Pharma International Ltd. |
Nanoparticulate insulin formulations
|
|
US20060003012A9
(en)
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
|
US20060052404A1
(en)
|
2001-10-26 |
2006-03-09 |
Rudolph Alfred R |
Pharmaceutical formulations comprising substituted xanthine compounds
|
|
JP2005515187A
(ja)
|
2001-11-26 |
2005-05-26 |
スーパージェン インコーポレイテッド |
ポリオキシエチル化ひまし油を使用する医薬組成物の調製方法
|
|
US20060078618A1
(en)
|
2001-12-11 |
2006-04-13 |
Constantinides Panayiotis P |
Lipid particles and suspensions and uses thereof
|
|
TWI287986B
(en)
|
2001-12-13 |
2007-10-11 |
Novartis Ag |
Use of Epothilones for the treatment of the carcinoid syndrome
|
|
ES2425738T3
(es)
|
2001-12-21 |
2013-10-17 |
Human Genome Sciences, Inc. |
Proteínas de fusión de la albúmina
|
|
US6890961B2
(en)
|
2002-02-01 |
2005-05-10 |
Micelle Products, Inc. |
Clear micellized formulations of β-carotene and method of treating leukoplakia
|
|
US20030162695A1
(en)
|
2002-02-27 |
2003-08-28 |
Schatzberg Alan F. |
Glucocorticoid blocking agents for increasing blood-brain barrier permeability
|
|
EP1485073A2
(en)
|
2002-03-20 |
2004-12-15 |
Advanced Inhalation Research, Inc. |
Method for administration of growth hormone via pulmonary delivery
|
|
US20050287203A1
(en)
|
2002-05-08 |
2005-12-29 |
Nijs De H |
Formulation comprising testosteron undecanoate and castor oil
|
|
CZ294371B6
(cs)
|
2002-06-10 |
2004-12-15 |
Pliva - Lachema, A. S. |
Stabilizovaná farmaceutická kompozice na bázi polyoxyethylovaného ricinového oleje a způsob její přípravy
|
|
FR2842736B1
(fr)
|
2002-07-26 |
2005-07-22 |
Flamel Tech Sa |
Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
|
|
JP4771697B2
(ja)
|
2002-09-24 |
2011-09-14 |
サントリーホールディングス株式会社 |
認知能力の正常応答の低下予防、改善又は向上作用を有する組成物
|
|
US7411039B2
(en)
|
2002-10-14 |
2008-08-12 |
Novo Nordisk A/S |
GLP-2 compounds, formulations, and uses thereof
|
|
US20040097419A1
(en)
|
2002-11-19 |
2004-05-20 |
Holger Petersen |
Organic compounds
|
|
SI1585548T1
(sl)
|
2002-12-09 |
2018-11-30 |
Abraxis Bioscience, Llc |
Sestave in metode odmerjanja farmakoloških sredstev
|
|
ATE419846T1
(de)
|
2003-02-07 |
2009-01-15 |
Prometic Biosciences Inc |
Fettsäuren mittlerer kettenlänge, glyceride und analoga als stimulatoren der erythropoiese
|
|
US7803781B2
(en)
|
2003-02-28 |
2010-09-28 |
Isis Pharmaceuticals, Inc. |
Modulation of growth hormone receptor expression and insulin-like growth factor expression
|
|
US20040185170A1
(en)
|
2003-03-21 |
2004-09-23 |
Shubha Chungi |
Method for coating drug-containing particles and formulations and dosage units formed therefrom
|
|
GB0307082D0
(en)
|
2003-03-27 |
2003-04-30 |
Gyne Ideas Ltd |
Drug delivery device and method
|
|
DE10328905B4
(de)
|
2003-06-26 |
2015-07-09 |
Hochland Natec Gmbh |
Form- und Kühlvorrichtung
|
|
EP1648472A2
(en)
|
2003-07-01 |
2006-04-26 |
Ranbaxy Laboratories, Ltd. |
Stable oral compositions of azithromycin monohydrate
|
|
US20060275253A1
(en)
|
2003-09-01 |
2006-12-07 |
Kazunari Ushida |
Beta hydroxy short to medium chain fatty acid polymer
|
|
JP2007523050A
(ja)
|
2003-09-17 |
2007-08-16 |
カイアズマ・リミテッド |
生物学的障壁を通した透過を容易にすることのできる組成物
|
|
CN1863505A
(zh)
|
2003-10-10 |
2006-11-15 |
卫材株式会社 |
新型液体制剂组合物
|
|
WO2005041901A2
(en)
|
2003-11-03 |
2005-05-12 |
Elixir Pharmaceuticals, Inc. |
Therapeutics using somatostatin agonists
|
|
US8865021B2
(en)
|
2003-11-07 |
2014-10-21 |
Camurus Ab |
Compositions of lipids and cationic peptides
|
|
AR046773A1
(es)
|
2003-12-23 |
2005-12-21 |
Novartis Ag |
Formulaciones farmaceuticas de bisfosfonatos
|
|
KR20060130723A
(ko)
|
2004-03-10 |
2006-12-19 |
쉐링 악티엔게젤샤프트 |
분자 분산된 드로스피레논을 포함하는 조성물
|
|
WO2005092914A1
(en)
|
2004-03-22 |
2005-10-06 |
Blue Mountain Technology Development Lab |
Process for promoting proper folding of human serum albumin using a human serum albumin ligand
|
|
NZ550320A
(en)
|
2004-04-15 |
2010-02-26 |
Chiasma Inc |
Compositions capable of facilitating penetration across a biological barrier
|
|
US20070219131A1
(en)
|
2004-04-15 |
2007-09-20 |
Ben-Sasson Shmuel A |
Compositions capable of facilitating penetration across a biological barrier
|
|
US20050256097A1
(en)
|
2004-05-11 |
2005-11-17 |
Kosan Biosciences, Inc. |
Pharmaceutical solution formulations containing 17-AAG
|
|
CN1960746A
(zh)
|
2004-05-25 |
2007-05-09 |
阿尔扎公司 |
稳定性提高的含生物分子配方
|
|
US20050266087A1
(en)
|
2004-05-25 |
2005-12-01 |
Gunjan Junnarkar |
Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium
|
|
WO2005117992A2
(en)
|
2004-05-30 |
2005-12-15 |
Cemines, Inc. |
Controlled delivery of therapeutic compounds
|
|
US20060002989A1
(en)
|
2004-06-10 |
2006-01-05 |
Ahmed Salah U |
Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same
|
|
EP1778187B1
(en)
|
2004-08-04 |
2012-05-23 |
Camurus Ab |
Compositions forming non-lamellar dispersions
|
|
JP4993852B2
(ja)
|
2004-09-17 |
2012-08-08 |
サントリーホールディングス株式会社 |
ストレスに起因する行動異常を伴う症状あるいは疾患の予防又は改善作用を有する組成物
|
|
US20060069055A1
(en)
|
2004-09-21 |
2006-03-30 |
Maya Dajee |
Delivery of polynucleotides
|
|
CN101160118A
(zh)
|
2005-02-24 |
2008-04-09 |
依兰药物国际有限公司 |
多西紫杉醇或其类似物的纳米微粒制剂
|
|
EP1871348A4
(en)
|
2005-03-01 |
2012-08-01 |
Sun Pharma Advanced Res Co Ltd |
PHARMACEUTICAL COMPOSITIONS WITH DELAYED RELEASE
|
|
WO2006099288A2
(en)
|
2005-03-11 |
2006-09-21 |
Indevus Pharmaceuticals, Inc. |
Controlled release formulations of octreotide
|
|
US7759312B2
(en)
|
2005-03-11 |
2010-07-20 |
Endo Pharmaceuticals Solutions Inc. |
Delivery of dry formulations of octreotide
|
|
EP1885384B1
(en)
|
2005-05-23 |
2016-03-23 |
Mayo Foundation For Medical Education And Research |
Treating liver diseases characterized by the presence of solitary ot multiple liver cysts
|
|
US7288520B2
(en)
|
2005-07-13 |
2007-10-30 |
Allergan, Inc. |
Cyclosporin compositions
|
|
US20070021325A1
(en)
|
2005-07-21 |
2007-01-25 |
Mediplex Corporation |
Drug formulation containing a solubilizer for enhancing solubility, absorption, and permeability
|
|
US20070066512A1
(en)
|
2005-09-12 |
2007-03-22 |
Dominique Verhelle |
Methods and compositions using immunomodulatory compounds for the treatment of disorders associated with low plasma leptin levels
|
|
FR2891459B1
(fr)
|
2005-09-30 |
2007-12-28 |
Flamel Technologies Sa |
Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant
|
|
CA2618705C
(en)
|
2005-11-07 |
2014-04-22 |
Murty Pharmaceuticals, Inc. |
Improved delivery of tetrahydrocannabinol
|
|
PT2275103E
(pt)
|
2005-11-21 |
2014-07-24 |
Novartis Ag |
Inibidores de mtor para o tratamento de tumores endócrinos
|
|
KR20140133968A
(ko)
|
2005-12-22 |
2014-11-20 |
노파르티스 아게 |
옥트레오티드 및 ２종 이상의 폴리락티드-코-글리콜리드 중합체를 포함하는 서방형 제제
|
|
TW200738269A
(en)
|
2006-02-09 |
2007-10-16 |
Univ Maryland |
Oral delivery of therapeutic agents using tight junction agonists
|
|
US20070190139A1
(en)
|
2006-02-13 |
2007-08-16 |
Intelgenx Corp. |
Delayed release pharmaceutical oral dosage form and method of making same
|
|
US20070224142A1
(en)
|
2006-03-22 |
2007-09-27 |
Swaile David F |
Hydrogenated castor oil based compositions as a replacement for petrolatum
|
|
MX2008012844A
(es)
|
2006-04-06 |
2009-01-19 |
Activbiotics Pharma Llc |
Composiciones farmaceuticas y usos de ellas.
|
|
RU2437662C2
(ru)
|
2006-04-07 |
2011-12-27 |
Меррион Рисерч Iii Лимитед |
Твердая пероральная лекарственная форма, содержащая усилитель
|
|
US8071136B2
(en)
|
2006-04-21 |
2011-12-06 |
Bioactives, Inc. |
Water-soluble pharmaceutical compositions of hops resins
|
|
JP2009539803A
(ja)
|
2006-06-08 |
2009-11-19 |
ノバルティス アクチエンゲゼルシャフト |
ソマトスタチン−アナログとドーパミン−または成長ホルモン受容体アンタゴニストの組合せ剤
|
|
WO2007146234A2
(en)
|
2006-06-09 |
2007-12-21 |
Merrion Research Ii Limited |
Solid oral dosage form containing an enhancer
|
|
US7998927B2
(en)
|
2006-06-23 |
2011-08-16 |
Aegis Therapeutics, Llc |
Stabilizing alkylglycoside compositions and methods thereof
|
|
KR100816065B1
(ko)
|
2006-11-27 |
2008-03-24 |
동국제약 주식회사 |
초기 방출억제 특성이 우수한 서방출성 마이크로캡슐의제조방법 및 이에 의해 제조되는 마이크로캡슐
|
|
US9918934B2
(en)
|
2006-12-12 |
2018-03-20 |
Edgar Joel Acosta-Zara |
Linker-based lecithin microemulsion delivery vehicles
|
|
US20090022727A1
(en)
|
2007-01-26 |
2009-01-22 |
Alza Corp. |
Injectable, nonaqueous suspension with high concentration of therapeutic agent
|
|
AU2008215659B2
(en)
|
2007-02-16 |
2012-11-01 |
Aska Pharmaceutical Co., Ltd. |
Pharmaceutical composition comprising microparticle oily suspension
|
|
DK2203181T3
(en)
|
2007-10-16 |
2018-05-28 |
Biocon Ltd |
An orally administrable solid composition and a method thereof
|
|
GB2454672A
(en)
|
2007-11-13 |
2009-05-20 |
Mologic Ltd |
Chromogenic protease substrates
|
|
US20110112010A1
(en)
|
2008-02-15 |
2011-05-12 |
The Government of the United States of America, as represented by The National Institutes of Health |
Octanoic acid formulations and methods of treatment using the same
|
|
CA2723558A1
(en)
|
2008-05-07 |
2009-11-12 |
Merrion Research Iii Limited |
Compositions of gnrh related compounds and processes of preparation
|
|
US9186412B2
(en)
|
2008-08-18 |
2015-11-17 |
Entera Bio Ltd. |
Methods and compositions for oral administration of insulin
|
|
BRPI0918652B1
(pt)
|
2008-09-17 |
2021-10-19 |
Chiasma, Inc. |
Composição farmacêutica compreendendo um meio hidrofóbico e uma forma sólida que compreende polipeptídeo e sal de ácido graxo de cadeia média, processo de produção da mesma e forma de dosagem oral
|
|
AR074603A1
(es)
*
|
2008-12-15 |
2011-01-26 |
Novartis Ag |
Formulacion de deposito de octreotida con niveles de exposicion constantemente altos.uso. metodo. kit
|
|
RU2012108851A
(ru)
|
2009-09-14 |
2013-10-27 |
Зинтес Гмбх |
Компрессионная пластинка с вариабельным углом
|
|
JP2011113487A
(ja)
|
2009-11-30 |
2011-06-09 |
Hochiki Corp |
警報器の設置方法、警報器および支持部材
|
|
WO2011112576A1
(en)
|
2010-03-10 |
2011-09-15 |
Ambrilia Biopharma Inc. |
Microspheres for sustained release of octreotide acetate
|
|
TWI633887B
(zh)
|
2012-05-31 |
2018-09-01 |
大塚製藥股份有限公司 |
用於預防及／或治療多囊性腎臟病之藥物
|
|
JP2015525243A
(ja)
|
2012-06-21 |
2015-09-03 |
アンジオジーン ファーマシューティカルズ リミテッド |
腫瘍症状を緩和するための方法および組成物
|
|
WO2014049515A1
(en)
|
2012-09-25 |
2014-04-03 |
Piramal Enterprises Limited |
Pyrrolidine substituted flavones for treatment of renal cystic diseases
|
|
CA2888462A1
(en)
|
2012-10-19 |
2014-04-14 |
Synta Pharmaceuticals Corp. |
Treating polycystic kidney disease with hsp90 inhibitory compounds
|
|
WO2016048984A1
(en)
|
2014-09-25 |
2016-03-31 |
Cortendo Ab (Publ) |
Methods and compositions for the treatment of cushing's syndrome using 2s, 4r ketoconazole
|
|
EP4321213A3
(en)
|
2014-12-10 |
2024-05-15 |
Amryt Endo, Inc. |
Oral octreotide administered in combination with other therapeutic agents
|
|
HUE071943T2
(hu)
*
|
2015-02-03 |
2025-10-28 |
Amryt Endo Inc |
Akromegália kezelése oktreotid orális alkalmazásával
|
|
JP2017014206A
(ja)
|
2015-06-30 |
2017-01-19 |
ナノアンティバイオティクス，インコーポレイテッド |
腹水の治療
|
|
CA3290933A1
(en)
|
2016-01-21 |
2025-11-29 |
Amryt Endo, Inc. |
Oral octreotide for the treatment of disease
|
|
EP3528828B1
(en)
|
2016-10-21 |
2025-01-29 |
Amryt Endo, Inc. |
Terlipressin composition for use in treating ascites
|
|
US20220202911A1
(en)
|
2020-12-28 |
2022-06-30 |
Amryt Endo, Inc. |
Oral octreotide therapy in combination with digoxin or lisinopril
|
|
US11141457B1
(en)
|
2020-12-28 |
2021-10-12 |
Amryt Endo, Inc. |
Oral octreotide therapy and contraceptive methods
|
|
CN118742305A
(zh)
|
2022-02-25 |
2024-10-01 |
阿迈特恩多有限公司 |
用于治疗疾病的口服奥曲肽
|